Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Deals

Duolingo rings up $35m
CMU-founded language learning platform developer Duolingo has now raised $183m altogether and has increased its valuation 60% to $2.4bn.
Juventas packs in Parkland-backed round
The property developer has backed Chinese Academy of Medical Sciences spinout Juventas to help advance its clinical-stage oncology cell therapy candidates.
Daily deal net: November 19, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Umoja taps into $53m series A
MPM Capital and Qiming Venture Partners USA have co-led a series A round for Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute.
Kandou caps off series C round
EPFL’s chip-link technology provider has added more than $36m to a Swisscom-backed round that now totals $92.3m, taking its total funding to almost $133m.
4DMT retries IPO with $75m filing
Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.
Hitachi spotlights VLC Photonics purchase
Polytechnic University of Valencia spinout VLC Photonics has been bought by Hitachi for an undisclosed sum nine years after it was founded.
Nereid tackles $50m series A
Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

News Continued

Purespring jumps into $59.5m series A
Syncona has launched Purespring to commercialise gene therapies aimed at kidney diseases that are based on work at University of Bristol.
Daily deal net: November 18, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: November 17, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sigilon signals $100m IPO target
Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.
Form Energy stores $70m
MIT-founded grid battery spinout Form Energy expects to reveal the round's investors within weeks after it pushed its overall funding to more than $120m.
Bridge Medicines crosses $10m
Existing backers Takeda, Deerfield and Bay City Capital have provided $10m to help progress research from multiple institutions.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg

Login